DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum
- PMID: 18516094
- PMCID: PMC2683475
- DOI: 10.1139/Y08-031
DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum
Abstract
The penis is kept in the flaccid state mainly via a tonic activity of norepinephrine and endothelins (ETs). ET-1 is important in salt-sensitive forms of hypertension. We hypothesized that cavernosal responses to ET-1 are enhanced in deoxycorticosterone acetate (DOCA)-salt mice and that blockade of ETA receptors prevents abnormal responses of the corpus cavernosum in DOCA-salt hypertension. Male C57BL/6 mice were unilaterally nephrectomized and treated for 5 weeks with both DOCA and water containing 1% NaCl and 0.2% KCl. Control mice were uninephrectomized and received tap water with no added salt. Animals received either the ETA antagonist atrasentan (5 mg x day(-1) x kg(-1) body weight) or vehicle. DOCA-salt mice displayed increased systolic blood pressure (SBP), and treatment with atrasentan decreased SBP in DOCA-salt mice. Contractile responses in cavernosal strips from DOCA-salt mice were enhanced by ET-1, phenylephrine, and electrical field stimulation (EFS) of adrenergic nerves, whereas relaxations were not altered by IRL-1620 (an ETB agonist), acetylcholine, sodium nitroprusside, and EFS of nonadrenergic noncholinergic nerves. PD59089 (an ERK1/2 inhibitor), but not Y-27632 (a Rho-kinase inhibitor), abolished enhanced contractions to ET-1 in cavernosum from DOCA-salt mice. Treatment of DOCA-salt mice with atrasentan did not normalize cavernosal responses. In summary, DOCA-salt treatment in mice enhances cavernosal reactivity to contractile, but not to relaxant, stimuli, via ET-1/ETA receptor-independent mechanisms.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2683475/bin/nihms81866f1.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2683475/bin/nihms81866f2.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2683475/bin/nihms81866f3.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2683475/bin/nihms81866f4.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2683475/bin/nihms81866f5.gif)
![Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2683475/bin/nihms81866f6.gif)
Similar articles
-
Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.J Sex Med. 2008 Dec;5(12):2793-807. doi: 10.1111/j.1743-6109.2008.01009.x. Epub 2008 Sep 24. J Sex Med. 2008. PMID: 18823320
-
Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.Hypertension. 2001 Sep;38(3 Pt 2):692-6. doi: 10.1161/01.hyp.38.3.692. Hypertension. 2001. PMID: 11566958
-
Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.Hypertension. 1999 Feb;33(2):759-65. doi: 10.1161/01.hyp.33.2.759. Hypertension. 1999. PMID: 10024341
-
Endothelin and endothelin antagonists in hypertension.J Hypertens. 1998 Dec;16(12 Pt 2):1891-5. doi: 10.1097/00004872-199816121-00007. J Hypertens. 1998. PMID: 9886874 Review.
-
Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.Am J Physiol. 1998 Jun;274(6):R1613-8. doi: 10.1152/ajpregu.1998.274.6.R1613. Am J Physiol. 1998. PMID: 9608015
Cited by
-
NLRP3 activation contributes to endothelin-1-induced erectile dysfunction.J Cell Mol Med. 2023 Jan;27(1):1-14. doi: 10.1111/jcmm.17463. Epub 2022 Dec 14. J Cell Mol Med. 2023. PMID: 36515571 Free PMC article.
-
A visualization system for erectile vascular dynamics.Front Cell Dev Biol. 2022 Oct 14;10:1000342. doi: 10.3389/fcell.2022.1000342. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36313553 Free PMC article.
-
Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine.EPMA J. 2021 Aug 4;12(3):265-305. doi: 10.1007/s13167-021-00248-z. eCollection 2021 Sep. EPMA J. 2021. PMID: 34367381 Free PMC article. Review.
-
Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction.J Sex Med. 2013 Sep;10(9):2154-64. doi: 10.1111/jsm.12245. Epub 2013 Jul 24. J Sex Med. 2013. PMID: 23889981 Free PMC article.
-
New insights into hypertension-associated erectile dysfunction.Curr Opin Nephrol Hypertens. 2012 Mar;21(2):163-70. doi: 10.1097/MNH.0b013e32835021bd. Curr Opin Nephrol Hypertens. 2012. PMID: 22240443 Free PMC article.
References
-
- Andersson KE. Pharmacology of penile erection. Pharmacol. Rev. 2001;53:417–450. PMID:11546836. - PubMed
-
- Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J. Urol. 2003;170:S6–S14. PMID:12853766. - PubMed
-
- Ari G, Vardi Y, Hoffman A, Finberg JP. Possible role for endothelins in penile erection. Eur. J. Pharmacol. 1996;307:69–74. PMID:8831106. - PubMed
-
- Beg SA, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat. J. Cereb. Blood Flow Metab. 2006;26:846–856. PMID:16251886. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous